Division of Health Services Research and Policy, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
Ann Med. 2022 Dec;54(1):2137-2150. doi: 10.1080/07853890.2022.2105391.
People who inject drugs (PWID) are at an amplified vulnerability for experiencing a multitude of harms related to their substance use, including viral (e.g. HIV, Hepatitis C) and bacterial infections (e.g. endocarditis). Implementation of evidence-based interventions, such as syringe services programs (SSPs), remains imperative, particularly in locations at an increased risk of HIV outbreaks. This study aims to identify communities in Florida that are high-priority locations for SSP implementation by examining state-level data related to the substance use and overdose crises.
State-level surveillance data were aggregated at the ZIP Code Tabulation Area (ZCTA) ( = 983) for 2017. We used confirmed cases of acute HCV infection as a proxy of injection drug use. Least Absolute Selection and Shrinkage Operator (LASSO) regression was used to develop a machine learning model to identify significant indicators of acute HCV infection and high-priority areas for SSP implementation due to their increased vulnerability to an HIV outbreak.
The final model retained three variables of importance: (1) the number of drug-associated skin and soft tissue infection hospitalizations, (2) the number of chronic HCV infections in people aged 18-39, and 3) the number of drug-associated endocarditis hospitalizations. High-priority SSP implementation locations were identified in both urban and rural communities outside of current Ending the HIV Epidemic counties.
SSPs are long researched, safe, and effective evidence-based programs that offer a variety of services that reduce disease transmission and assist with combating the overdose crisis. Opportunities to increase services in needed regions across the state now exist in Florida as supported by the expansion of the Infectious Disease Elimination Act of 2019. This study provides details where potential areas of concern may be and highlights regions where future evidence-based harm reduction programs, such as SSPs, would be useful to reduce opioid overdoses and disease transmission among PWID.Key messagesThe rate of acute HCV in Florida in 2017 was 1.9 per 100,000, nearly twice the national average.Serious injection related infections among PWID are significant indicators of acute HCV infection.High-priority SSP implementation locations in Florida were identified in both urban and rural communities, including those outside of current counties.
注射毒品者(PWID)更容易受到与药物使用相关的多种伤害,包括病毒(例如 HIV、丙型肝炎)和细菌感染(例如心内膜炎)的影响。实施基于证据的干预措施,如注射器服务项目(SSP)仍然至关重要,特别是在 HIV 爆发风险增加的地方。本研究旨在通过检查与药物使用和过量用药危机相关的州级数据,确定佛罗里达州需要优先实施 SSP 的社区。
2017 年,州级监测数据在邮政编码区(ZCTA)( = 983)进行了汇总。我们使用急性 HCV 感染的确诊病例作为注射药物使用的替代指标。使用最小绝对选择和收缩算子(LASSO)回归建立机器学习模型,以确定急性 HCV 感染的显著指标和由于易受 HIV 爆发影响而需要优先实施 SSP 的高风险地区。
最终模型保留了三个重要变量:(1)与药物相关的皮肤和软组织感染住院人数,(2)18-39 岁人群中的慢性 HCV 感染人数,以及 3)与药物相关的心内膜炎住院人数。在当前结束艾滋病毒流行县以外的城市和农村社区中确定了高优先级 SSP 实施地点。
SSP 是经过长期研究、安全有效的循证项目,提供了多种服务,可减少疾病传播并有助于应对过量用药危机。随着 2019 年传染病消除法案的扩大,佛罗里达州现在有机会在全州范围内需要服务的地区增加服务。本研究提供了潜在关注领域的详细信息,并强调了未来 SSP 等基于证据的减少伤害项目有用的地区,以减少 PWID 中的阿片类药物过量和疾病传播。
2017 年佛罗里达州急性 HCV 感染率为每 10 万人 1.9 例,接近全国平均水平。
PWID 中严重的注射相关感染是急性 HCV 感染的重要指标。
在佛罗里达州,包括当前县以外的城市和农村社区,都确定了 SSP 的高优先级实施地点。